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ABSTRACT
We systematically reviewed papers published in English between 1994 and October 2015
on how postnatal weight gain and growth affect neurodevelopment and metabolic
outcomes in term-born small-for-gestational-age (SGA) infants. Two randomised trials
reported that enriched infant formulas that promoted early growth also increased fat mass,
lean mass and blood pressure (BP), but had no effect on early neurocognitive outcomes.
Meanwhile, 31 observational studies reported consistent positive associations between
postnatal weight gain and growth with neurocognitive outcomes, adiposity, insulin
resistance and BP.
Conclusion: Few intervention studies exist, despite consistent positive associations
between early growth and neurocognition in term-born SGA infants.
INTRODUCTION
Many infants who are small at birth tend to gain weight
more rapidly during the early postnatal period. This catch-
up growth may be advantageous in certain populations of
low-birthweight children, with potential short-term benefi-
cial effects on survival and longer-term benefits on cognitive
development and stature (1). Conversely, accelerated post-
natal weight gain and catch-up growth has also been
associated with an increased risk of adiposity and metabolic
disease later in life (2–4). A wealth of evidence indicates
that events in early life can influence the risk of later
disease. It is well established that developmental plasticity
allows organisms to adapt their phenotype through
epigenetic, metabolic and, or, anatomical processes, in
response to certain stimuli (5). However, if the actual
conditions do not match the ones predicted, the adaptation
Abbreviations
AGA, Appropriate for gestational age; BMI, Body mass index;
BP, Blood pressure; RCT, Randomised controlled trial; SGA,
Small for gestational age.
Key Notes
 This systematic review covering 1994–2015 focused on
how postnatal weight gain and growth affect neuro-
development and metabolic outcomes in term-born
small-for-gestational-age infants.
 Two randomised trials reported that enriched infant
formulas that promoted early growth also increased fat
mass, lean mass and blood pressure (BP), but not
neurocognitive outcomes.
 Observational studies reported consistent positive asso-
ciations between postnatal weight gain and growth
with neurocognitive outcomes, adiposity, insulin resis-
tance and BP.
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can have an adverse impact on long-term health, leading to
disease (6). Associations have been widely observed
between low birthweight and later noncommunicable dis-
eases, such as type 2 diabetes (7). Evidence from animal and
human models has led to the suggestion that those associ-
ations with low birthweight are mediated, in part, by rapid
postnatal weight gain and catch-up growth leading to
excessive adiposity (8,9).
Low birthweight may be due to a number of different
reasons, including intrauterine growth restriction and
preterm birth. We previously reviewed the relationship
between postnatal growth rates, cognitive outcomes and the
risk of disease in preterm infants (10). That review
concluded that more research was needed to understand
how to optimise growth in preterm infants and to achieve
neurocognitive benefits while minimising the risk of later
disease. However, the effects of rapid postnatal weight gain
need to be considered separately in different populations of
low-birthweight infants, as the benefits and the risks may
differ between preterm infants and full-term infants born
small for gestational age (SGA). In preterm infants, catch-
up growth may be beneficial for neurodevelopment (11,12),
particularly if catch-up in length and height is achieved, and
this may outweigh the potential long-term metabolic costs.
Being born SGA also constitutes a risk factor for the
development of diseases later in life, as these infants are
likely to experience accelerated postnatal weight and body
fat gain (13). SGA is commonly defined as birthweight and,
or, length that is at least two standard deviation scores
below the mean for gestational age (14), although some
publications set the cut-off below the third, fifth or 10th
percentile (15–17). The minus two standard deviation
scores definition is likely to capture the majority of infants
with impaired foetal growth. While numerous studies have
identified associations between early postnatal weight gain
or body fat gain with later disease risk factors, not many
have specifically evaluated populations of full-term SGA
infants.
The aim of this review was to identify and summarise the
published evidence on postnatal weight gain and growth in
term-born SGA infants, with regard to the potential neu-
rodevelopmental benefits and adverse metabolic outcomes.
It also attempts to identify critical postnatal windows
during which growth might influence these outcomes.
METHODS
A systematic search of electronic databases was performed
using ProQuest Dialog. The Medline and EMBASE data-
bases were combined to identify studies published between
1994 and October 2015 that reported associations between
postnatal growth patterns and later metabolic and neu-
rocognitive outcomes in term infants born SGA. Relevant
studies prior to 2005 were obtained from the review by
Baird (18).
Search terms representing the following categories were
combined: (i) the population, such as term infants or SGA,
(ii) postnatal growth, including catch-up growth, early
growth and failure to thrive, (iii) outcomes related to
metabolic diseases such as adiposity, insulin resistance and
cardiovascular risk or to neurocognitive development, such
as neurodevelopment and the intelligence quotient. One
author (EC-M) carried out the search and assessed the titles
and abstracts to identify relevant studies. Then, the full-text
papers of the potentially eligible studies were screened and
selected for inclusion in the systematic review if they met
the specific selection criteria. An additional hand search of
reference lists of relevant and related papers was made to
ensure a complete collection. Around 200 full-text papers
were reviewed (Fig. 1).
Inclusion and exclusion criteria
The search terms for the study population were the
following: small for gestational age, SGA, intrauterine
growth restriction, IUGR, growth restricted, growth
retarded, low birthweight and not preterm. Only studies
on infants born at term were included. Studies that also
reported preterm data were only included if the findings
were presented separately.
With regard to exposure, special attention was given to
using a definition of growth that considered changes in
weight and, or, height between at least two time points,
such as birth to 16 weeks, rather than measurements of
body size at one specific age. Growth was also accepted if
reported as absolute velocity or as a change in standard
deviation scores. In the latter case, the growth reference
used needed to be reported. Studies were accepted if the
outcome was assessed at the same age as the second growth
measurement or later.
The metabolic outcomes that we considered were related
to body composition – such as overweight, obesity and
adiposity – insulin resistance, glucose tolerance or cardio-
vascular risk, including the blood lipid profile and blood
pressure (BP). The neurodevelopmental outcome measures
included: neurodevelopment, cognition, intelligence quo-
tient, motor function and behaviour. No limit was applied
regarding the subjects’ ages at the time of the outcome
assessment. The earliest was four months and the latest was
in 21-year-old young adults.
Both intervention and observational studies were
accepted. Intervention studies were selected if the inter-
vention influenced postnatal growth and the study assessed
at least one of the outcomes mentioned above.
The search was limited to studies in humans and original
papers published in English. Studies were excluded if the
body size was only reported at one time point. Concerns
about the eligibility of specific studies were resolved by
seeking a second opinion from another author (KK). When
further assessment was needed, consensus was reached by
other authors (ECG, KG, KKO). Only published data were
considered, and no further data were requested from study
authors. Additional studies suggested by co-authors for
possible inclusion were considered, but no new eligible
studies were identified this way.
One author (EC-M) was responsible for the data extrac-
tion, tabulation and preliminary interpretation of the 34
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individual reports, of which six examined neurodevelop-
mental outcomes and 28 examined metabolic outcomes.
As 16 (47%) of these papers reported several outcomes of
interest, they were used more than once.
Data were retrieved using specifically designed forms that
included the study design, timing and nature of the
exposure, number of participants and age at follow-up
measurements. A summary result indicator was attributed
to each study, whether it reported a positive effect and, or,
the association between postnatal growth and the outcome
measure. A summary result indicator was attributed to each
study, whether it reported a positive effect and, or,
association between postnatal growth and the outcome
measure: (++) statistically significant positive association;
(+) non-significant positive trend; (0) no association; ()
non-significant inverse trend; and () significant inverse
association.
A quantitative summary of the data by meta-analysis
could not be undertaken due to the heterogeneity of the
studies in terms of the measurement of the exposure,
outcome variables and timing of measurements between
studies. A descriptive methodology was chosen, and the
results are presented as a narrative synthesis.
To ensure the study quality, three authors (EC-M, KK,
KKO) independently assessed the methodological quality of
the observational studies using the Newcastle–Ottawa Scale
(19). This assessment evaluates study quality in relation to
the control of confounding variables, adequate sample size,
minimisation of selection bias and definition of exposure.
Studies were given scores: the selection of the study groups
could score a maximum of four points, the comparability of
the study groups could score a maximum of two points, and
the ascertainment of the outcome could score a maximum
of three points. The highest possible score was nine.
RESULTS
We included 34 papers on postnatal weight gain and
growth in term infants born SGA (summarised in Tables 1
and 2): most of these (n = 31) described observational
studies, with only three papers from the same group
describing different outcomes from two intervention stud-
ies (20–22). With regard to study quality, the majority were
rated as moderate or high quality. Only five studies were
considered to be of low quality, with a score of four or less.
These are noted in Tables 1 and S1a–c.
Neurocognitive outcomes
Only one randomised controlled trial (RCT) (20) promoted
early growth in SGA infants using a nutrient- and energy-
enriched formula – with higher protein, lipids, carbohydrate
and micronutrient contents – and reported neurocognitive
outcomes. The enriched formula group had a lower devel-
opmental quotient than the standard formula group at the
age of nine months and no difference in neurocognitive
outcomes measured using the Bayley Mental Development
and Psychomotor Development indexes at the age of
18 months (Table 1).
In total, four observational studies comprising 9373
children (Table 1) reported that faster postnatal growth in
weight, length and, or, height or head circumference
between birth and 20 months to five years was associated
with better neurocognitive outcomes at the ages of 17 to
26 years (23–26). One further study comprising 503 chil-
dren reported a quadratic association: both low and high
weight gains between birth and nine months were associ-
ated with lower cognitive function at the age of seven years
(27). Most observational studies adjusted for a variety of
potential confounding factors, although none adjusted for
maternal intelligence quotient. Only one study compared
SGA infants versus an appropriate for gestational age
(AGA) control group: this study found lower cognitive
function in SGA than AGA children (27).
Adiposity
One paper reported two RCTs comprising 545 children
(22). Both RCTs showed that nutrient- and energy-enriched
formulas, which promoted early growth, also increased total
Figure 1 Flow chart of search strategy and selection of relevant studies.
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body fat mass in SGA-born children at the age of five to
seven years, along with a trend for increased total body lean
mass (Table S1a).
There were 18 independent observational studies that
reported on the association between postnatal growth and
some measures of adiposity: Table S1a–c show the findings
stratified by outcome measure. Faster postnatal growth,
measured as weight, length and, or, height or body mass
index (BMI) between birth and one to eight years were
positively associated with BMI at the ages of one to
21 years (14,16,28–36), as reported in 11 studies compris-
ing 784 children. However, three further studies comprising
120 children reported no association between postnatal
growth, measured as the weight between birth and two to
seven years and BMI at the ages of two to seven years (37–
39). Faster postnatal growth, measured as the weight gain
between birth and four to seven years, was positively
associated with the percentage of body fat at the ages of
two to 11 years in three studies comprising 1311 children
(34,35,38), whereas two further studies comprising 165
children reported no association between postnatal growth,
measured as the weight gain between birth and one year of
age, and the percentage of body fat at the ages of one to
21 years (40,41). Furthermore, faster growth, measured as
the weight gain between birth and two to seven years, was
positively associated with total body fat mass at the ages of
two to seven years in two studies comprising 247 children
(36,39). However, another study comprising 106 children
showed no association between postnatal growth, in terms
of the weight gain between birth and 21 years, and total
body fat mass at the age of 21 years (42). Using total body
lean mass at the ages of seven to 21 years as an outcome
measure, a positive association was found with faster
growth in terms of weight gain between birth and seven to
21 years in two studies comprising 162 children (39,42). In
contrast, another study comprising 29 children reported an
inverse relationship between weight gain from birth to two
years and total body lean mass at the age of two to four
years (38). Meanwhile, in two studies comprising 79
children, abdominal fat mass at the ages of one to four
years was positively associated with faster growth, mea-
sured as the weight gain between birth and two to four years
(38,43). Finally, five of the 11 observational studies, which
comprised 1513 children including AGA controls, reported
that the SGA group had significantly lower total body
adiposity measured as the percentage of body fat and, or,
BMI compared to the AGA group at the ages of one to
seven years (15,28,30,33,34). Conversely, two studies com-
prising 194 children reported that those born SGA had
significantly higher adiposity, measured as a percentage of
Table 1 Postnatal growth in full-term SGA infants related to later neurocognitive outcomes
WT gain Timing of exposure
N
SGA Age at outcome Summary result Comments Adjustment
Randomised controlled trials
Morley 2004M (20) B-9 mo
(Nutrient-enriched
formula)
299 9 mo
18 mo
– (9 mo)
0 (18 mo)
At 9 mo, enriched formula group
had lower developmental quotient
than the standard formula group
At 18 mo, no difference was seen in
Bayley MDI or PDI scores
Sex, age, maternal
education, social class
Observational studies (n = 5)
Pylipow 2009M (27) B-4 mo
(WT gain)
503 7 y 
(inverted
J-shape)
Both fast or slow WT gain to age
4 mo associated with
lower WISC
Sex, race, SES
Jensen 2015M (25) B-3 mo
B-17 y
(HT gain, HC gain)
47 17 y +
(B-3 mo)
++
(B-17 y)
HT gain to age 3 mo showed a
positive trend with IQ
HT gain to age 17 y was positively
associated with IQ
Sex, age, parental SES,
maternal age
Horta 2009M (24) B-20 mo
(WT gain)
20–42 mo
(WT gain)
1822 18 y ++
(B-20 mo)
0
(20–42 mo)
WT gain to age 20 mo, but not
between 20 and 42 mo, was
positively associated with achieved
schooling
Parental education,
household assets, SES
Lundgren 2001M (26) B-18 y
(WT gain)
6440 18 y ++ WT gain was positively associated with
IP and PP
Birthweight and length
Strauss 2000M (23) B-5 y
(HC gain)
1064 26 y ++ HC gain was positively associated with
professional attainment and a
positive trend with income
Sex, parental SES,
neonatal distress
Reports are ordered by study design and age at outcome assessment.
B, birth; MDI, mental developmental index; PDI, psychomotor developmental index; WT, weight; HT, height or length; IP, intellectual performance; PP,
psychological performance; SES, socioeconomic status; WISC, Wechsler intelligence scale for children; HC, head circumference; y, years; mo, months.
Study quality: Low (L), 0–4 points in the Newcastle–Ottawa Scale; moderate (M), 5–7 points; high (H), 8–9 points.
++, statistically significant positive association; +, non-significant positive trend; 0, no association; , non-significant inverse trend; , significant inverse
association.
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body fat, and a higher subscapular-to-triceps skinfold ratio
compared to the AGA group at the ages of two to eight
years (38,44).
Insulin resistance
No RCTs included any measure of insulin resistance as
the outcome (Table S1a), but 12 studies comprising 763
children reported that faster postnatal growth, measured as
the weight gain between birth and eight to 21 years, was
positively associated with insulin resistance at the ages of
one to 21 years, using the homeostatic model assessment
for insulin resistance, fasting insulin, oral glucose tolerance
test, intravenous glucose tolerance test and clamp
(15,16,29,33,35,38,39,41,44–47). A further six studies com-
prising 356 children reported no association between
postnatal growth, measured as weight, height or BMI
between birth to eight years, and insulin resistance at the
ages of one to eight years, using the homeostatic model
assessment for insulin resistance or fasting insulin
(17,30,31,37,40,43) (Table S1b). Positive associations were
reported by eight studies with adjustments for current
adiposity and four studies without. Of the 13 studies that
included AGA controls, 10 studies reported that the SGA
group had significantly higher insulin resistance, measured
as fasting insulin, oral glucose tolerance test, intravenous
glucose tolerance test and clamp, than the AGA group at
the ages of one to 21 years (15,16,29,33,35,38,41,45–47).
Blood pressure
Only one RCT, comprising 153 children, reported that a
nutrient- and energy-enriched formula given from the age of
four days to nine months promoted weight gain and
increased the risk of high BP at six to nine years (21)
(Table S1c). In four observational studies comprising 3180
children, including an observational study among breastfed
children (21), faster postnatal growth measured as the
weight gain between birth and two to eight years was
positively associated with a higher risk of high BP at the
ages of seven to 15 years (21,44,48,49). In contrast, one
further study comprising 106 children reported no
Table 2 Summary of findings relating postnatal growth in full-term small-for-gestational-age infants to neurocognitive and metabolic outcomes in the 34 identified papers
Outcomes Study design No. of studies No. of subjects Summary of findings
Neurocognition Randomised trial 1 299 Enriched formula from birth to nine months increased infancy weight gain and
length growth, but there was no difference in Bayley’s score at 18 months
Observational 5 1482 4/5 studies (n = 979) reported early growth was positively associated with
cognition at ages 17 to 26 years. 1/5 study (n = 503) reported both fast
growth and slow early growth were associated with lower intelligence
quotient at seven years
Body mass index (BMI) Observational 14 2151 11/14 studies (n = 2031) reported early growth was positively associated
with BMI. 3/14 studies (n = 120) reported no association between early
growth and later BMI
Per cent body fat Randomised trial 1 299 Enriched formula increased infancy weight gain and length growth and also
increased per cent body fat at ages six to eight years
Observational 5 1476 2/5 studies (n = 54) reported early growth was positively associated with
per cent body fat at ages two to four years. 3/5 studies (n = 1412)
reported no association between early growth and later per cent body fat
at ages four months to 21 years
Fat and lean mass Randomised trial 1 246 Enriched formula increased infancy weight gain and length growth and also
increased fat mass at ages five to seven years.
Observational 6 591 5/6 studies (n = 486) reported early weight gain was positively associated
with fat mass at ages one to eight years. 1/6 study (n = 106) reported
early weight gain was positively associated with lean mass but not fat
mass at age 21 years
Insulin resistance Observational 12 1119 12/18 studies (n = 763) reported weight gain (birth to 7–21 years) was
positively associated with insulin resistance. 6/18 studies (n = 356)
reported no association between postnatal growth and later insulin
resistance
Blood pressure Randomised trial 1 153 Enriched formula increased infancy weight gain and length growth and also
increased the risk of higher blood pressure at six to nine years
Observational 4 3180 3/4 studies (n = 3074) reported early weight gain was positively associated
with blood pressure at ages 6 to 15 years. 1/4 study (n = 106) reported
no association between early weight gain with blood pressure at age
21 years
Lipids Observational 7 585 1/7 study (n = 165) reported early weight gain was positively associated with
total cholesterol and triglycerides at age eight years. 6/7 studies
(n = 420) reported no association between early weight gain with later
lipid profiles
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association between weight gain at birth to 21 years with
BP at the age of 21 years. Instead, that study reported a
positive association between weight gain and carotid intima
media thickness at 21 years of age (42). None of the four
studies that included AGA controls reported that the SGA
group had significantly higher BP than the AGA group at
the ages of seven to 21 years (42,44,48,49).
Serum lipid concentrations
No RCTs were reported with blood lipid levels as the
outcome, but seven observational studies reported on the
association between postnatal weight gain or growth and
blood lipid levels (Table S1c) and these studies varied
widely in measures of early growth and lipid parameters.
Only one study comprising 165 children reported that faster
weight gain between birth to eight years was positively
associated with higher total cholesterol and triglycerides at
the age of eight years (44). In contrast, a further five studies
comprising 364 children reported no association between
postnatal growth between the ages of zero and one to eight
years and lipid levels in terms of total cholesterol, low-
density lipoprotein, high-density lipoprotein or triglycerides
at the ages of one to eight years (15,17,31,37,45). Further-
more, three studies comprising 189 children reported that
faster height or length gain between birth and five to eight
years was negatively associated with total cholesterol, low-
density lipoprotein and high-density lipoprotein (17,31,50).
Only one of the seven studies that included an AGA control
group reported that the SGA group, particularly those with
poor height growth, had significantly higher total choles-
terol compared to the AGA group at the age of 12 years
(50).
DISCUSSION
This review of postnatal weight gain and growth in relation
to neurocognitive and metabolic outcomes in term-born
SGA children only found two RCTs that met the eligibility
criteria. The same RCT was reported with differing out-
comes in three papers (20–22), and a second RCT was also
described by the Singhal et al. paper (22). These trials
showed that nutrient- and energy-enriched formulas that
promoted early growth increased fat mass and also demon-
strated some increases in lean body mass and increased BP.
There was no benefit on neurocognitive outcomes.
The observational studies generally reported consistent
associations between postnatal weight gain or growth with
neurocognitive outcomes, adiposity, insulin resistance and
BP. Postnatal weight gain appeared to be beneficial for
neurocognitive outcomes, but seemed to have adverse
effects on adiposity and related markers of metabolic health.
However, it is important to consider the metabolic risks that
SGA individuals face in the context of the general popula-
tion. Compared to AGA controls, SGA groups had higher
insulin resistance, but lower total adiposity – albeit most
commonly assessed by BMI – and no evidence for higher BP.
Most of the observational studies were of moderate to
high quality. The four studies rated as low quality were
distributed across the outcome categories and their exclu-
sion would have had little or no impact on the conclusions.
We were unable to perform meta-analyses due to the high
variability in age at outcome and the paucity of comparable
outcome measures. However, we found consistent obser-
vational evidence for most outcomes.
Only one study compared SGA to an AGA control group
with regard to neurocognitive outcomes (25). However,
one other review reported lower verbal and performance
intelligence quotient scores in school-age children born
SGA (51) and neuroimaging studies have shown early
microstructural changes related to altered neurobehavioral
outcomes (52). We found consistently positive associations
between postnatal growth and neurocognitive outcomes in
four of the five observational studies included in the review
(51). Interestingly, the only RCT included in this review
reported a negative effect of growth induced by nutrient-
and energy-enriched formula feeding on developmental
scores at nine months in just girls, but no differences
between nutritional groups at 18 months. The discordance
between the RCT and the observational studies in the
review (51) may have been due to the early age at which
neurocognitive outcomes were measured in the RCT – nine
and 18 months – compared to the observational studies at
seven to 26 years. Alternatively, residual confounding
factors may have remained in the observational studies.
For example, comorbidities that arose during the neonatal
period might have had an adverse impact on both growth
and neurocognition.
For adiposity and metabolic outcomes, most studies
considered the period of postnatal weight gain exposure
as birth to the age at outcome. In such analyses, the
influence of growth would be dominated by the current
body size. This was the case for: 11 of 14 studies for BMI;
three of five studies for per cent body fat; four of six studies
for fat mass; 15 of 18 studies for insulin resistance, and two
out of four studies for BP, although in all cases the
remaining studies all reported significant positive asso-
ciations. Hence, the exclusion of such studies did not
materially alter the conclusions. However, there were
insufficient data with discrete periods of postnatal weight
gain to estimate the presence of critical, early windows of
weight gain or growth associated with later outcomes.
Despite the consistent evidence for a positive association
between postnatal weight gain and adiposity, SGA individ-
uals continued, on average, to have less adipose than AGA
individuals. With the exception of two observational studies
that measured abdominal fat, adipose tissue distribution
was not evaluated among the outcomes. The possibility that
SGA children accumulate greater visceral adiposity than
AGA children without greater BMI or total body fat cannot
be discarded.
Only one of the seven observational studies reported a
positive association between postnatal weight gain or
growth and blood total cholesterol levels. However, these
studies only included children only up to age 12 years old
and we note that total cholesterol is an imprecise marker in
cardiovascular disease risk in children due to their higher
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proportion of high-density lipoprotein to low-density
lipoprotein cholesterol.
The observational studies were set across diverse geo-
graphical regions. This was a strength of the evidence base
as most full-term SGA infants are born in low-income and
middle-income countries (53) and these babies face higher
risks of postnatal growth failure. It is possible that it is not
weight gain that predicts metabolic and disease outcome,
but rather the infancy gains in lean versus fat mass and, or,
changes in fat mass distribution. However, few studies to
date have related changes in infancy body composition to
later outcomes.
Interpretation for policy and recommendations for future
studies
In general, SGA infants face an increased risk of short
stature, with average adult heights being approximately one
standard deviation score below the mean population height
(54). However, faster postnatal growth and weight gain can
lead to taller adult heights, but this study did not review that
factor (54). Although the evidence for a similar positive
impact on neurocognitive outcomes is relatively sparse, the
potential for such long-term benefits on height and neu-
rocognition makes the promotion of infancy weight gain an
appealing policy. On the other hand, insulin resistance is
higher in SGA catch-up children than in the general
population and this finding is supported by consistent
evidence on the association between low birthweight and
type 2 diabetes (7).
Regarding long-term cardiovascular disease risks, prena-
tal growth restriction can result in prenatal circulatory
adaptations and altered heart and vascular tree develop-
ment (55) and one study reported that weight gain over the
long period from birth to 21 years was positively associated
with carotid intima media thickness at 21 years (42). We
found consistent experimental and observational evidence
linking postnatal weight gain and growth to higher BP.
Nevertheless, none of the studies reported higher BP in
SGA versus AGA groups and, as discussed above, the
evidence on lipid outcomes was inconsistent. Thus, the
relevance of postnatal growth to cardiovascular disease risk
in SGA individuals remains unclear.
Establishing the optimal growth patterns in term-born
SGA infants to minimise short-term and long-term risks is
crucial. It has been proposed that reaching around the 30th
weight percentile in the first postnatal months and around
the 50th percentile by the age of seven may prevent the risks
of adverse outcomes (56). However, that hypothesis was
only based on observational data and it remains a challenge
to safely promote infancy growth in SGA, let alone attain
such a narrow growth target. Furthermore, whether such
growth patterns are appropriate across settings that differ in
exposure to infections and risk of malnutrition is unknown.
CONCLUSION
This review summarises the published evidence on post-
natal weight gain and, or, growth in term-born SGA
infants, regarding the potential neurodevelopmental bene-
fits and adverse metabolic outcomes. Only two RCTs were
identified, including one that reported on neurocognitive
outcomes and found no effect. Overall, 31 observational
studies did report consistent positive associations between
postnatal weight gain and, or, growth with neurocognitive
outcomes, adiposity, insulin resistance and BP.
In conclusion, our systematic review highlights hard it
was to find RCTs that focused on promoting growth in
full-term SGA infants. There is great potential for such
interventions to have long-term benefits on height and
neurocognition without significant negative effects on
metabolic health, but there remains a substantial knowledge
gap on the impact of nutritional interventions on growth
in this population, especially in low-income and middle-
income settings. Further observational studies that include
repeated postnatal anthropometric measurements would
allow us to identify possible critical windows of growth
associated with differing health outcomes and more studies
assessing neurocognitive outcomes are needed. Finally,
future prospective studies should assess the potential
contribution of body composition, rather than total body
weight gain on later outcomes. It is plausible that the
potential benefits of postnatal growth on neurocognitive
and other outcomes are related to gains in lean body mass,
whereas gains in body fat mass, in particular central fat,
might predict insulin resistance and related adverse meta-
bolic and health outcomes.
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